Vascular closure devices are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. The devices seal the puncture site in an artery (the arteriotomy) through mechanical means rather than relying on the body’s natural clotting response.
The North America regions suggest an array of opportunities for growth and are likely to be getting into the eyes of new investors in the vascular closure market. Growth is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The Vascular closure market is expected to grow steadily in the forecast period. The factors driving the growth of this market are increasing catheterization related procedures (PCI), preference for minimally-invasive solutions & rise in vascular procedures. Ease in usage and quick hemostatic properties of VCDs and increased utilization of transradial arterial access are some of the opportunities that are propelling the growth of the market.
High price of products, complications associated with VCD, less adoption of novel technologies in emerging countries are hampering the market of vascular closure. Reduced reimbursement, usage of animal related sources and lower revenue potential of VCD are threats for the market growth.
The global Vascular Closure Devices (VCDS) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Vascular Closure Devices (VCDS) market based on company, product type, end user and key regions.
This report studies the global market size of Vascular Closure Devices (VCDS) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Vascular Closure Devices (VCDS) in these regions.
This research report categorizes the global Vascular Closure Devices (VCDS) market by top players/brands, region, type and end user. This report also studies the global Vascular Closure Devices (VCDS) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abbott Laboratories
St. Jude Medical
Cardinal Health
Morrris Innovative
Market size by Product
5F-6F
5F-21F
Market size by End User
Angiography Surgery
Interventional Procedures
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Vascular Closure Devices (VCDS) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Vascular Closure Devices (VCDS) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Vascular Closure Devices (VCDS) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Vascular Closure Devices (VCDS) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Vascular Closure Devices (VCDS) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Vascular Closure Devices (VCDS) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Vascular Closure Devices (VCDS) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Vascular Closure Devices (VCDS) Market Size Growth Rate by Product
1.4.2 5F-6F
1.4.3 5F-21F
1.5 Market by End User
1.5.1 Global Vascular Closure Devices (VCDS) Market Size Growth Rate by End User
1.5.2 Angiography Surgery
1.5.3 Interventional Procedures
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Vascular Closure Devices (VCDS) Market Size
2.1.1 Global Vascular Closure Devices (VCDS) Revenue 2014-2025
2.1.2 Global Vascular Closure Devices (VCDS) Sales 2014-2025
2.2 Vascular Closure Devices (VCDS) Growth Rate by Regions
2.2.1 Global Vascular Closure Devices (VCDS) Sales by Regions
2.2.2 Global Vascular Closure Devices (VCDS) Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Vascular Closure Devices (VCDS) Sales by Manufacturers
3.1.1 Vascular Closure Devices (VCDS) Sales by Manufacturers
3.1.2 Vascular Closure Devices (VCDS) Sales Market Share by Manufacturers
3.1.3 Global Vascular Closure Devices (VCDS) Market Concentration Ratio (CR5 and HHI)
3.2 Vascular Closure Devices (VCDS) Revenue by Manufacturers
3.2.1 Vascular Closure Devices (VCDS) Revenue by Manufacturers (2014-2019)
3.2.2 Vascular Closure Devices (VCDS) Revenue Share by Manufacturers (2014-2019)
3.3 Vascular Closure Devices (VCDS) Price by Manufacturers
3.4 Vascular Closure Devices (VCDS) Manufacturing Base Distribution, Product Types
3.4.1 Vascular Closure Devices (VCDS) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vascular Closure Devices (VCDS) Product Type
3.4.3 Date of International Manufacturers Enter into Vascular Closure Devices (VCDS) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Vascular Closure Devices (VCDS) Sales by Product
4.2 Global Vascular Closure Devices (VCDS) Revenue by Product
4.3 Vascular Closure Devices (VCDS) Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Vascular Closure Devices (VCDS) Breakdown Data by End User
6 North America
6.1 North America Vascular Closure Devices (VCDS) by Countries
6.1.1 North America Vascular Closure Devices (VCDS) Sales by Countries
6.1.2 North America Vascular Closure Devices (VCDS) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Vascular Closure Devices (VCDS) by Product
6.3 North America Vascular Closure Devices (VCDS) by End User
7 Europe
7.1 Europe Vascular Closure Devices (VCDS) by Countries
7.1.1 Europe Vascular Closure Devices (VCDS) Sales by Countries
7.1.2 Europe Vascular Closure Devices (VCDS) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Vascular Closure Devices (VCDS) by Product
7.3 Europe Vascular Closure Devices (VCDS) by End User
8 Asia Pacific
8.1 Asia Pacific Vascular Closure Devices (VCDS) by Countries
8.1.1 Asia Pacific Vascular Closure Devices (VCDS) Sales by Countries
8.1.2 Asia Pacific Vascular Closure Devices (VCDS) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Vascular Closure Devices (VCDS) by Product
8.3 Asia Pacific Vascular Closure Devices (VCDS) by End User
9 Central & South America
9.1 Central & South America Vascular Closure Devices (VCDS) by Countries
9.1.1 Central & South America Vascular Closure Devices (VCDS) Sales by Countries
9.1.2 Central & South America Vascular Closure Devices (VCDS) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Vascular Closure Devices (VCDS) by Product
9.3 Central & South America Vascular Closure Devices (VCDS) by End User
10 Middle East and Africa
10.1 Middle East and Africa Vascular Closure Devices (VCDS) by Countries
10.1.1 Middle East and Africa Vascular Closure Devices (VCDS) Sales by Countries
10.1.2 Middle East and Africa Vascular Closure Devices (VCDS) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Vascular Closure Devices (VCDS) by Product
10.3 Middle East and Africa Vascular Closure Devices (VCDS) by End User
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Company Business Overview
11.1.3 Abbott Laboratories Vascular Closure Devices (VCDS) Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Abbott Laboratories Vascular Closure Devices (VCDS) Products Offered
11.1.5 Abbott Laboratories Recent Development
11.2 St. Jude Medical
11.2.1 St. Jude Medical Company Details
11.2.2 Company Business Overview
11.2.3 St. Jude Medical Vascular Closure Devices (VCDS) Sales, Revenue and Gross Margin (2014-2019)
11.2.4 St. Jude Medical Vascular Closure Devices (VCDS) Products Offered
11.2.5 St. Jude Medical Recent Development
11.3 Cardinal Health
11.3.1 Cardinal Health Company Details
11.3.2 Company Business Overview
11.3.3 Cardinal Health Vascular Closure Devices (VCDS) Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Cardinal Health Vascular Closure Devices (VCDS) Products Offered
11.3.5 Cardinal Health Recent Development
11.4 Morrris Innovative
11.4.1 Morrris Innovative Company Details
11.4.2 Company Business Overview
11.4.3 Morrris Innovative Vascular Closure Devices (VCDS) Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Morrris Innovative Vascular Closure Devices (VCDS) Products Offered
11.4.5 Morrris Innovative Recent Development
12 Future Forecast
12.1 Vascular Closure Devices (VCDS) Market Forecast by Regions
12.1.1 Global Vascular Closure Devices (VCDS) Sales Forecast by Regions 2019-2025
12.1.2 Global Vascular Closure Devices (VCDS) Revenue Forecast by Regions 2019-2025
12.2 Vascular Closure Devices (VCDS) Market Forecast by Product
12.2.1 Global Vascular Closure Devices (VCDS) Sales Forecast by Product 2019-2025
12.2.2 Global Vascular Closure Devices (VCDS) Revenue Forecast by Product 2019-2025
12.3 Vascular Closure Devices (VCDS) Market Forecast by End User
12.4 North America Vascular Closure Devices (VCDS) Forecast
12.5 Europe Vascular Closure Devices (VCDS) Forecast
12.6 Asia Pacific Vascular Closure Devices (VCDS) Forecast
12.7 Central & South America Vascular Closure Devices (VCDS) Forecast
12.8 Middle East and Africa Vascular Closure Devices (VCDS) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vascular Closure Devices (VCDS) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
